The steady approval of new biosimilars in recent years provides additional safe, effective, and cost-effective options for ...

Results of a meta-analysis showed that all biologic agents were superior to placebo for improving short-term outcomes in moderate to severe plaque psoriasis.

Greater baseline disease pruritus and quality of life impairment are associated with higher rates of super response to dupilumab in patients with AD.

Adjuvant pembrolizumab improved recurrence-free survival among patients with resected Merkel cell carcinoma, but not significantly.

Patients with vitiligo have an increased prevalence of autoimmune comorbidities, including thyroid disorders, psoriasis, and rheumatoid arthritis.

Patients with resected stage IIIB-C or stage IV melanoma had better long-term outcomes with nivolumab vs ipilimumab.

Neutrogena recalled some lots of its Makeup Remover Ultra-Soft Cleansing Towelettes due to possible bacterial contamination.

Investing in wellness programs for nurses improves retention and reduces burnout, according to study results presented at ...

The combination of pembrolizumab and EVX-01, a personalized peptide-based neoantigen cancer vaccine, demonstrated activity in patients with advanced melanoma, according to phase 2 study results.

Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial ...

Older women who achieved at least 4000 steps per day at least once per week had lower risk of mortality and for cardiovascular disease.

Patients with HS with severe disease have greater cardiometabolic risk factors and ASCVD risk than patients with mild or moderate disease.